Latest News and Press Releases

RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100...

Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical Market Size & Growth Analysis: According to SNS Insider, The Biopharmaceutical Market Size was valued at USD 572.33 Billion in 2023...

Certara, a global leader in model-informed drug development, today announced the celebration of the 25th anniversary of the Simcyp® Consortium.

Certara has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel.

Certara Cloud is a unifying platform that integrates Certara's scientific software. Clients use a single ID to access and manage their licensed software.

New York, United States, March 05, 2024 (GLOBE NEWSWIRE) -- The medical affairs function is gaining importance in the pharmaceutical, biotechnology, medical device, and diagnostic sectors of the...

Selbyville, Delaware, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Preclinical CRO market value is set to reach USD 11 billion by 2032, according to a new research report by Global Market Insights Inc. ...

Portland, OR, Oct. 27, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global cellulite treatment market was estimated at $2.1 billion in 2021 and...

PRINCETON, N.J., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the feature release of Pinnacle 21 Enterprise 5.1.0, which updates...

PRINCETON, N.J., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of D360 version 21.5, an industry-leading scientific...